This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


06Jul 2020

Back to News overview

Thesis defense Ieva Kurilova – interventional oncology

Few people know that a subset of patients with metastatic cancer can be treated with minimally invasive local therapies. PhD researcher Ieva Kurilova has analyzed the outcomes of patients treated with such interventional oncology procedures. Interventional oncology is a relatively new specialty that uses minimally invasive techniques under image-guidance (such as CT or ultrasound) to achieve precise tumor targeting for cancer in different organs in the body. In selected patients with metastatic colorectal cancer interventional oncology therapies can help achieve long-term disease control and improved survival. With thermal ablation, for example, physicians can use special electrodes through the skin to apply heat and destroy the tumor. Or they can use radioembolization, by injecting very small radioactive particles in the tumor vessels that irradiate the tumor cells internally and kill them. Ieva will defend her thesis on July 7th. Good luck Ieva!

Collage Kurilova Leva Blauw

More information

  • PhD defense (online): Maastricht University, 7 July at 14:00 - 15:15
  • Livestream via:
  • Thesis title: Interventional Oncology in the Management of Metastatic Colorectal Cancer
  • Promotors: Prof. Dr. Regina G.H. Beets-Tan (Netherlands Cancer Institute and Maastricht University) and Prof. Dr. Constantinos T. Sofocleous (Memorial Sloan Kettering Cancer Center)
Share this page